• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CTR1 沉默通过限制铜进入内皮细胞来抑制血管生成。

CTR1 silencing inhibits angiogenesis by limiting copper entry into endothelial cells.

机构信息

R. S. Mehta Jain Department of Biochemistry and Cell Biology, Vision Research Foundation, Chennai, India ; Birla Institute of Technology and Science, Pilani (Rajasthan), India.

出版信息

PLoS One. 2013 Sep 9;8(9):e71982. doi: 10.1371/journal.pone.0071982. eCollection 2013.

DOI:10.1371/journal.pone.0071982
PMID:24039729
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3767743/
Abstract

Increased levels of intracellular copper stimulate angiogenesis in human umbilical vein endothelial cells (HUVECs). Copper transporter 1 (CTR1) is a copper importer present in the cell membrane and plays a major role in copper transport. In this study, three siRNAs targeting CTR1 mRNA were designed and screened for gene silencing. HUVECs when exposed to 100 µM copper showed 3 fold increased proliferation, migration by 1.8-fold and tube formation by 1.8-fold. One of the designed CTR1 siRNA (si 1) at 10 nM concentration decreased proliferation by 2.5-fold, migration by 4-fold and tube formation by 2.8-fold. Rabbit corneal packet assay also showed considerable decrease in matrigel induced blood vessel formation by si 1 when compared to untreated control. The designed si 1 when topically applied inhibited angiogenesis. This can be further developed for therapeutic application.

摘要

细胞内铜水平升高可刺激人脐静脉内皮细胞(HUVEC)血管生成。铜转运蛋白 1(CTR1)是一种存在于细胞膜上的铜转运体,在铜转运中起主要作用。在这项研究中,设计并筛选了三种针对 CTR1 mRNA 的 siRNA 进行基因沉默。当 HUVEC 暴露于 100µM 铜时,增殖增加了 3 倍,迁移增加了 1.8 倍,管形成增加了 1.8 倍。在 10 nM 浓度下,设计的 CTR1 siRNA(si1)使增殖减少了 2.5 倍,迁移增加了 4 倍,管形成增加了 2.8 倍。兔角膜包被实验也表明,与未处理的对照组相比,si1 可显著减少基质胶诱导的血管生成。设计的 si1 局部应用可抑制血管生成。这可以进一步开发用于治疗应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4967/3767743/e46eed554dad/pone.0071982.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4967/3767743/f1914261f0e2/pone.0071982.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4967/3767743/0e7933d53931/pone.0071982.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4967/3767743/d3649621eb43/pone.0071982.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4967/3767743/9d32c5e86a49/pone.0071982.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4967/3767743/b511f6d2caba/pone.0071982.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4967/3767743/e46eed554dad/pone.0071982.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4967/3767743/f1914261f0e2/pone.0071982.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4967/3767743/0e7933d53931/pone.0071982.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4967/3767743/d3649621eb43/pone.0071982.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4967/3767743/9d32c5e86a49/pone.0071982.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4967/3767743/b511f6d2caba/pone.0071982.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4967/3767743/e46eed554dad/pone.0071982.g006.jpg

相似文献

1
CTR1 silencing inhibits angiogenesis by limiting copper entry into endothelial cells.CTR1 沉默通过限制铜进入内皮细胞来抑制血管生成。
PLoS One. 2013 Sep 9;8(9):e71982. doi: 10.1371/journal.pone.0071982. eCollection 2013.
2
Copper uptake by DMT1: a compensatory mechanism for CTR1 deficiency in human umbilical vein endothelial cells.二价金属离子转运体1对铜的摄取:人脐静脉内皮细胞中铜转运蛋白1缺陷的一种代偿机制
Metallomics. 2015 Aug;7(8):1285-9. doi: 10.1039/c5mt00097a. Epub 2015 Jun 12.
3
Changes in copper concentrations affect the protein levels but not the mRNA levels of copper chaperones in human umbilical vein endothelial cells.铜浓度的变化会影响人脐静脉内皮细胞中铜伴侣蛋白的水平,但不会影响其mRNA水平。
Metallomics. 2014 Mar;6(3):554-9. doi: 10.1039/c3mt00138e. Epub 2013 Dec 17.
4
Paxillin regulates vascular endothelial growth factor A-induced in vitro angiogenesis of human umbilical vein endothelial cells.桩蛋白调节血管内皮生长因子A诱导的人脐静脉内皮细胞体外血管生成。
Mol Med Rep. 2015 Mar;11(3):1784-92. doi: 10.3892/mmr.2014.2961. Epub 2014 Nov 17.
5
Suppression of NHE1 by small interfering RNA inhibits HIF-1α-induced angiogenesis in vitro via modulation of calpain activity.通过小干扰 RNA 抑制 NHE1 可通过调节钙蛋白酶活性抑制体外 HIF-1α诱导的血管生成。
Microvasc Res. 2011 Mar;81(2):160-8. doi: 10.1016/j.mvr.2010.12.004. Epub 2010 Dec 24.
6
Cysteine oxidation of copper transporter CTR1 drives VEGFR2 signalling and angiogenesis.半胱氨酸氧化的铜转运蛋白 CTR1 驱动 VEGFR2 信号转导和血管生成。
Nat Cell Biol. 2022 Jan;24(1):35-50. doi: 10.1038/s41556-021-00822-7. Epub 2022 Jan 13.
7
Peptides derived from histidine and methionine-rich regions of copper transporter 1 exhibit anti-angiogenic property by chelating extracellular Cu.组氨酸和富含蛋氨酸的铜转运蛋白 1 区域衍生肽通过螯合细胞外 Cu 表现出抗血管生成特性。
Chem Biol Drug Des. 2018 Mar;91(3):797-804. doi: 10.1111/cbdd.13145. Epub 2017 Dec 6.
8
Role of endogenous insulin gene enhancer protein ISL-1 in angiogenesis.内源性胰岛素基因增强子蛋白ISL-1在血管生成中的作用。
Mol Vis. 2016 Dec 2;22:1375-1386. eCollection 2016.
9
The effects of small interfering RNA-targeting tissue factor on an in vitro model of neovascularization.靶向组织因子的小干扰RNA对血管生成体外模型的影响。
Mol Vis. 2013 Jun 11;19:1296-303. Print 2013.
10
Relative contribution of CTR1 and DMT1 in copper transport by the blood-CSF barrier: implication in manganese-induced neurotoxicity.CTR1 和 DMT1 在血脑屏障铜转运中的相对贡献:锰诱导神经毒性的意义。
Toxicol Appl Pharmacol. 2012 May 1;260(3):285-93. doi: 10.1016/j.taap.2012.03.006. Epub 2012 Mar 18.

引用本文的文献

1
The molecular mechanism and therapeutic landscape of copper and cuproptosis in cancer.癌症中铜及铜死亡的分子机制与治疗前景
Signal Transduct Target Ther. 2025 May 9;10(1):149. doi: 10.1038/s41392-025-02192-0.
2
The Journey of Copper-Impregnated Dressings in Wound Healing: From a Medical Hypothesis to Clinical Practice.含铜敷料在伤口愈合中的历程:从医学假设到临床实践
Biomedicines. 2025 Feb 24;13(3):562. doi: 10.3390/biomedicines13030562.
3
Copper in cancer: friend or foe? Metabolism, dysregulation, and therapeutic opportunities.

本文引用的文献

1
Bevacizumab and intraocular tumors: an intriguing paradox.贝伐单抗与眼内肿瘤:一个耐人寻味的悖论。
Mol Vis. 2012;18:2454-67. Epub 2012 Oct 5.
2
Side effects of anti-angiogenic drugs.抗血管生成药物的副作用。
Thromb Res. 2012 Apr;129 Suppl 1:S50-3. doi: 10.1016/S0049-3848(12)70016-6.
3
Copper is required for cobalt-induced transcriptional activity of hypoxia-inducible factor-1.铜对于钴诱导的缺氧诱导因子-1 的转录活性是必需的。
癌症中的铜:是友还是敌?代谢、失调及治疗机遇
Cancer Commun (Lond). 2025 May;45(5):577-607. doi: 10.1002/cac2.70005. Epub 2025 Feb 13.
4
Cuproplasia and cuproptosis, two sides of the coin.铜代谢异常和铜死亡,一枚硬币的两面。
Cancer Commun (Lond). 2025 May;45(5):505-524. doi: 10.1002/cac2.70001. Epub 2025 Jan 25.
5
Emerging nanomaterials for novel wound dressings: From metallic nanoparticles and MXene nanosheets to metal-organic frameworks.用于新型伤口敷料的新兴纳米材料:从金属纳米颗粒和MXene纳米片到金属有机框架。
Heliyon. 2024 Oct 22;10(21):e39611. doi: 10.1016/j.heliyon.2024.e39611. eCollection 2024 Nov 15.
6
Copper Dyshomeostasis and Diabetic Complications: Chelation Strategies for Management.铜稳态失衡与糖尿病并发症:螯合治疗策略
Mini Rev Med Chem. 2025;25(4):277-292. doi: 10.2174/0113895575308206240911104945.
7
Reversal of atherosclerosis by restoration of vascular copper homeostasis.通过恢复血管铜稳态逆转动脉粥样硬化。
Exp Biol Med (Maywood). 2024 Jun 24;249:10185. doi: 10.3389/ebm.2024.10185. eCollection 2024.
8
Cuproptosis in cancer: biological implications and therapeutic opportunities.铜死亡在癌症中的作用:生物学意义和治疗机会。
Cell Mol Biol Lett. 2024 Jun 25;29(1):91. doi: 10.1186/s11658-024-00608-3.
9
Single-cell and bulk RNA-seq unveils the immune infiltration landscape associated with cuproptosis in cerebral cavernous malformations.单细胞和批量RNA测序揭示了与脑海绵状血管畸形中铜死亡相关的免疫浸润格局。
Biomark Res. 2024 Jun 5;12(1):57. doi: 10.1186/s40364-024-00603-y.
10
Unveiling the promising anticancer effect of copper-based compounds: a comprehensive review.揭示铜基化合物的抗癌潜力:全面综述
J Cancer Res Clin Oncol. 2024 Apr 25;150(4):213. doi: 10.1007/s00432-024-05641-5.
J Pharmacol Exp Ther. 2012 Aug;342(2):561-7. doi: 10.1124/jpet.112.194662. Epub 2012 May 22.
4
Targeted therapies for renal cell carcinoma: review of adverse event management strategies.肾细胞癌的靶向治疗:不良反应管理策略综述。
J Natl Cancer Inst. 2012 Jan 18;104(2):93-113. doi: 10.1093/jnci/djr511. Epub 2012 Jan 10.
5
Inhibition of matrix metalloproteinase 14 (MMP-14)-mediated cancer cell migration.抑制基质金属蛋白酶 14(MMP-14)介导的癌细胞迁移。
J Biol Chem. 2011 Sep 23;286(38):33167-77. doi: 10.1074/jbc.M111.256644. Epub 2011 Jul 27.
6
Transient metals enhance cytotoxicity of curcumin: potential involvement of the NF-kappaB and mTOR signaling pathways.过渡金属增强姜黄素的细胞毒性:潜在涉及 NF-κB 和 mTOR 信号通路。
Anticancer Res. 2010 Sep;30(9):3249-55.
7
Unexpected role of the copper transporter ATP7A in PDGF-induced vascular smooth muscle cell migration.铜转运体 ATP7A 在血小板衍生生长因子诱导的血管平滑肌细胞迁移中的意外作用。
Circ Res. 2010 Sep 17;107(6):787-99. doi: 10.1161/CIRCRESAHA.110.225334. Epub 2010 Jul 29.
8
RNAi-based treatment for neovascular age-related macular degeneration by Sirna-027.基于 RNAi 的 Sirna-027 治疗新生血管性年龄相关性黄斑变性。
Am J Ophthalmol. 2010 Jul;150(1):33-39.e2. doi: 10.1016/j.ajo.2010.02.006.
9
Ctr1 transports silver into mammalian cells.Ctr1 将银转运进入哺乳动物细胞。
J Trace Elem Med Biol. 2010 Jul;24(3):178-84. doi: 10.1016/j.jtemb.2010.01.009. Epub 2010 Feb 12.
10
C(alpha)-trace model of the transmembrane domain of human copper transporter 1, motion and functional implications.人铜转运蛋白 1 的跨膜域的 C(alpha)-trace 模型,运动与功能的意义。
Proc Natl Acad Sci U S A. 2010 Jun 15;107(24):10908-13. doi: 10.1073/pnas.0914717107. Epub 2010 Jun 1.